Increased frequency of the angiotensin-converting enzyme gene D-allele is associated with noninfectious pulmonary dysfunction following allogeneic stem cell transplant

Bone Marrow Transplantation

Volumn 36, Issue 7, 2005, Pages 617-620

  Onizuka, Moni ^a   Kasai, M ^b   Oba, T ^b   Atsuta, Y ^c   Terakura, S ^c   Suzuki, R ^d   Kitaori, K ^b   Miyamura, K ^b   Hotta, T ^a   Kodera, Y ^b  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Angiotensin converting enzyme polymorphism; Noninfectious pulmonary dysfunction

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DIPEPTIDYL CARBOXYPEPTIDASE; MELPHALAN; METHOTREXATE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INCIDENCE; JAPAN; LIVING DONOR; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ALLELES; FEMALE; FIBROSIS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HETEROZYGOTE; HLA ANTIGENS; HUMANS; JAPAN; LUNG; LUNG DISEASES; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PROPORTIONAL HAZARDS MODELS; TRANSPLANTATION, HOMOLOGOUS;

EID: 30944441227     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705105     Document Type: Article

References (24)

1. Afessa B, Litzow MR, Tefferi A. Bronchiolitis obliterans and other late onset noninfectious pulmonary complications in hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 28: 425-434.
2. Kantrow SP, Hackman RC, Boeckh M et al. Idiopathic pneumonia syndrome: changing spectrum of lung injury after marrow transplantation. Transplantation 1997; 63: 1079-1086.
3. Crawford SW, Hackman RC. Clinical course of idiopathic pneumonia after bone marrow transplantation. Am Rev Respir Dis 1993; 147: 1393-1400.
4. Soubani AO, Miller KB, Hassoun PM. Pulmonary complication of bone marrow transplantation. Chest 1996; 109: 1066-1077.
5. Palmas A, Tefferi A, Myers JL et al. Late-onset noninfectious pulmonary complications after bone marrow transplantation. Br J Haematol 1998; 100: 680-687.
6. Rigat B, Hubert C, Alhenc-Gelas F et al. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
7. Cohen EP, Molteni A, Carone FA et al. Captopril preserves function and ultrastructure in experimental radiation nephropathy. Lab Invest 1996; 75: 349-360.
8. Linz W, Scholkens BA, Ganten D. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens 1989; A11: 1325-1350.
9. Morrison CD, Papp AC, Hejmanowski AQ et al. Increased D allele frequency of the angiotensin-converting enzyme gene in pulmonary fibrosis. Hum Pathol 2001; 32: 521-528.
10. Yousem SA. The histological spectrum of pulmonary graft-versus-host disease in bone marrow transplant recipients. Hum Pathol 1995; 26: 668-675.
11. Rigat B, Hubert C, Corvol P et al. PCR detection of the insertion/ deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992; 20: 1433.
12. Clark JG, Hansen JA, Hertz MI et al. NHLBI workshop summary. Idiopathic pneumonia syndrome after bone marrow transplantation. Am Rev Respir Dis 1993; 147: 1601-1606.
13. Higaki J, Baba S, Katsuya T et al. Deletion allele of angiotensin-converting enzyme gene increases risk of essential hypertension in Japanese men: The Suita Study. Circulation 2000; 101: 2060-2065.
14. Campbell DJ, Kladis A, Valentijn AJ. Effect of losartan on angiotensin and bradykinin peptides and angiotensin converting enzyme. J Cardiovasc Pharmacol 1995; 26: 233-240.
15. Bullock GR, Steyaert I, de Gasparo M et al. Distribution of type-1 and type-2 angiotensin receptors in the normal human lung and in lungs from patients with chronic obstructive pulmonary disease. Histochem Cell Biol 2001; 115: 117-124.
16. Specks U, Martin II WJ, Rohrbach MS. Bronchoalveolar lavage fluid angiotensin-concerting enzyme in interstitial lung disease. Am Rev Respir Dis 1990; 141: 117-123.
17. Idell S, Kueppers F, Lippmann M et al. Angiotensin converting enzyme in bronchoalveolar lavage in ARDS. Chest 1987; 91: 52-56.
18. Marshall RP, Peter G, Laurent GJ. Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol 2004; 286: L156-L164.
19. Fukuda T, Hackman RC, Madtes DK et al. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood 2003; 102: 2777-2785.
20. Shankar G, Cohen DA. Idiopathic pneumonia syndrome after bone marrow transplantation: The role of pre-transplant radiation conditioning and local cytokine dysregulation in promoting lung inflammation and fibrosis [review]. Int J Exp Pathol 2001; 82: 101-113.
21. Hildebrandt GC, Olkiewicz KM, Cooke KR et al. Donor-derived TNF-a regulates pulmonary chemokine expression and the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation. Blood 2004; 104: 586-593.
22. Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis [review]. N Engl J Med 2001; 345: 517-525.
23. Wang R, Ibarra.-Sunga O, Verlinski L et al. Abrogation of bleomycin-inducd epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 2000; 279: L143-L151.
24. Molteni A, Moulder JE, Cohen EF et al. Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker. Int J Radiat Biol 2000; 76: 523-532.